PharmaCyte Biotech Inc (PMCB)

[rudygerner]

Lol! The upcoming trial in pc will undoubtedly serve to put the Cell-in-a-Box® on the map, so to speak, but it's the diabetes treatment big pharma will ultimately be after - significantly more revenue potential.

Regarding the upcoming trial in LAPC, if the patients experience an improvement in their quality of life and/or tumor remission then the FDA will approve Cell-in-a-Box® for pc, which then makes the diabetes treatment worth that much more.

I intend to retain more than half of my position into diabetes, unless PMCB/Austrianova get bought together, which is looking more and more likely given the events of the last three months.